Disease/Infection News

RSS

D614G mutation enhances stability of SARS-CoV-2 spike protein

A new study, published on the preprint server bioRxiv in November 2020 by researchers at the Indian Institute of Science, has explored this issue further. The researchers have found that this mutation is associated with structural and energetic changes that cause this spike variant to become more available during infection, thus rendering the associated strain more infective.

4 Nov 2020

UC researcher recommends screening teen emergency room patients for STIs

A University of Cincinnati researcher is recommending pediatric hospital emergency rooms consider screening for sexually transmitted infections (STI) teenage and young adult patients who visit for other acute care issues.

4 Nov 2020

Ozone water found to rapidly inactivate SARS-Cov-2

As the coronavirus disease 19 (COVID-19) pandemic appears here to stay, a new study published on the preprint server bioRxiv* in November 2020 reports an effective and rapid inactivation tactic for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); namely, through the use of ozone water.

4 Nov 2020

People treated with statins have 22% to 25% lower risk of dying from COVID-19

Coronavirus has infected more than 40 million people around the world and has caused more than a million deaths in less than a year.

4 Nov 2020

RNA-binding proteins may suppress antiviral defenses against SARS-CoV-2

Conducted by researchers in South Korea at the Institute for Basic Science and the International Vaccine Institute, a new study published on the preprint server bioRxiv in November 2020 describes the many host proteins that bind with the ribonucleic acid (RNA) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and regulate the replication of the virus.

4 Nov 2020

Texas A&M study identifies four significant predictors of COVID-19 cases

In March 2020, New York City, an icon of America, was unfortunately named an early epicenter of the novel coronavirus. Now seven months later, America faces a new surge in coronavirus cases and researchers at Texas A&M University hope to provide information and context to help with the battle ahead.

4 Nov 2020

Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines

A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – both as a standalone treatment and in combination with FDA-approved remdesivir. The study is currently available on the bioRxiv preprint server.

4 Nov 2020

Black, Latinx hospital workers at highest risk for SARS-CoV-2 infection, study finds

Support staff and Black and Latinx hospital employees with and without patient care responsibilities are at highest risk for SARS-CoV-2 infection in health care settings, a Rutgers study found.

4 Nov 2020

Correlations found between 'long-COVID' patients and preexisting health conditions

Researchers from the nference (a biotech information firm) in Cambridge, MA, USA, the Mayo Clinic in Rochester, MN, USA, and nference Labs based in Bengaluru, India, recently performed a retrospective analysis of 266 COVID-19 patients.

4 Nov 2020

Living with children does not increase adults’ risk of severe COVID-19, say researchers

Researchers working on behalf of NHS England have found no evidence that adults who live with school-age children are at any increased risk of severe outcomes following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

4 Nov 2020

Will an effective COVID-19 vaccine return life to normal in the US?

A new study has shown that the extent to which social distancing restrictions and face mask usage could be relaxed in the United States during the coronavirus disease 2019 (COVID-19) pandemic would greatly depend on how effective a vaccine is and the proportion of the population it covered.

4 Nov 2020

Chikungunya can infect central nervous system and impair cognitive, motor functions

A study conducted by an international team of researchers with FAPESP's support shows that infection by chikungunya virus can produce even more severe manifestations than the typical symptoms of the disease, such as acute fever, headache, rash, and intense joint and muscle pain.

4 Nov 2020

Rise in negative health behaviors during lockdown connected to poor mental health in Scotland

A rise in negative health behaviours - such as lack of sleep, exercise and an unhealthy diet - is connected to poorer mental health during the tightest restrictions of Scotland's COVID-19 lockdown, a new study has confirmed.

4 Nov 2020

Delirium accompanied by fever could be an early symptom of COVID-19

Delirium accompanied by fever could bean early symptom of COVID-19. This is the main conclusion drawn by a scientific research review carried out by researchers from the Universitat Oberta de Catalunya.

4 Nov 2020

Lions and tigers and anteaters? US scientists scan the menagerie for COVID

As COVID-19 cases surge in the U.S., one Texas veterinarian has been quietly tracking the spread of the disease — not in people, but in their pets.

4 Nov 2020

First EUA point-of-care (POC/Waived/Fingerstick) COVID-19 antibody test now available from Carolina Liquid Chemistries.

The Fastep® COVID-19 IgG/IgM Rapid Test Device by Assure Tech., distributed in the USA by Carolina Liquid Chemistries, has received FDA Emergency Use Authorization for use.

From Carolina Liquid Chemistries Corp. 4 Nov 2020

Europe is the main source of COVID-19 spread, shows study

The University of Huddersfield's Archaeogenetics Research Group has mapped out the dispersal of the SARS-CoV-2 coronavirus, responsible for the current worldwide COVID-19 pandemic, putting Europe centre-stage as the main source of the spread.

4 Nov 2020

New system wirelessly captures data from pulse oximeters for COVID-19 monitoring

Automating the collection and presentation of healthcare data is crucial in the fight against COVID-19 - it adds capacity to screening efforts by automating routine tasks, thereby allowing frontline staff such as dormitory operators and healthcare workers in community care facilities to focus on more pressing tasks while receiving regular updates on the health status of the individuals under their care.

4 Nov 2020

Study sheds light on possible lung damage caused by COVID-19 virus

The study, published today in The Lancet's eBioMedicine, by King's College London in collaboration with University of Trieste and the International Centre for Genetic Engineering and Biology in Italy, shows the unique characteristics to the SARS-CoV-2 virus and may explain why patients suffer from 'long COVID'.

4 Nov 2020

Discoverey of four SARS-CoV-2 Mpro inhibitors, boceprevir, calpain inhibitors II and XII and GC-376

A team of scientists from the United States has recently revealed that small molecule inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease exhibit potent antiviral activity. These inhibitors show better efficacy when used in combination with antiviral medicine Remdesivir. The study is currently available on the bioRxiv* preprint server.

3 Nov 2020

Disease/Infection News

D614G mutation enhances stability of SARS-CoV-2 spike protein

UC researcher recommends screening teen emergency room patients for STIs

Ozone water found to rapidly inactivate SARS-Cov-2

People treated with statins have 22% to 25% lower risk of dying from COVID-19

RNA-binding proteins may suppress antiviral defenses against SARS-CoV-2

Texas A&M study identifies four significant predictors of COVID-19 cases

Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines

Black, Latinx hospital workers at highest risk for SARS-CoV-2 infection, study finds

Correlations found between 'long-COVID' patients and preexisting health conditions

Living with children does not increase adults’ risk of severe COVID-19, say researchers

Will an effective COVID-19 vaccine return life to normal in the US?

Chikungunya can infect central nervous system and impair cognitive, motor functions

Rise in negative health behaviors during lockdown connected to poor mental health in Scotland

Delirium accompanied by fever could be an early symptom of COVID-19

Lions and tigers and anteaters? US scientists scan the menagerie for COVID

First EUA point-of-care (POC/Waived/Fingerstick) COVID-19 antibody test now available from Carolina Liquid Chemistries.

Europe is the main source of COVID-19 spread, shows study

New system wirelessly captures data from pulse oximeters for COVID-19 monitoring

Study sheds light on possible lung damage caused by COVID-19 virus

Discoverey of four SARS-CoV-2 Mpro inhibitors, boceprevir, calpain inhibitors II and XII and GC-376

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Latest News